All Journals > Clinical Infectious Diseases > 1 November 2009 > Aspirin and 1918–19 Influenza Mortality

Article Tools

Search for Related Articles

Announcements

CID LISTED AMONG
“MOST INFLUENTIAL”

Clinical Infectious Diseases has been named as one of the "100 Most Influential Journals in Biology and Medicine" of the past 100 years by the Special Libraries Association. The list was compiled by the 680-plus members of SLA’s Biomedical and Life Sciences Division.

See the full list here.

Source: The DBIO 100, the 100 Most Influential Journals in Biology & Medicine over the last 100 Years

Press Release

Zambian Study Finds Longer Breastfeeding Best for HIV-Infected Mothers

Syphilis Survey Reveals Need for Accurate Testing for Early Infection

1 November 2009

Volume 49, Number 9
Clinical Infectious Diseases 2009;49:1405–1410
1058-4838/2009/4909-0020$15.00
DOI: 10.1086/606060
VIEWPOINTS

Salicylates and Pandemic Influenza Mortality, 1918–1919 Pharmacology, Pathology, and Historic Evidence

Karen M. Starko

Burlingame, California

The high case‐fatality rate—especially among young adults—during the 1918–1919 influenza pandemic is incompletely understood. Although late deaths showed bacterial pneumonia, early deaths exhibited extremely “wet,” sometimes hemorrhagic lungs. The hypothesis presented herein is that aspirin contributed to the incidence and severity of viral pathology, bacterial infection, and death, because physicians of the day were unaware that the regimens (8.0–31.2 g per day) produce levels associated with hyperventilation and pulmonary edema in 33% and 3% of recipients, respectively. Recently, pulmonary edema was found at autopsy in 46% of 26 salicylate‐intoxicated adults. Experimentally, salicylates increase lung fluid and protein levels and impair mucociliary clearance. In 1918, the US Surgeon General, the US Navy, and the Journal of the American Medical Association recommended use of aspirin just before the October death spike. If these recommendations were followed, and if pulmonary edema occurred in 3% of persons, a significant proportion of the deaths may be attributable to aspirin.

Received 29 March 2009; accepted 25 June 2009; electronically published 29 September 2009.

Reprints or correspondence: Dr Karen M. Starko, 1515 Floribunda Ave, Burlingame, CA 94010 ().

In February 1919…Edward’s fever kept getting higher and higher…aspirin…was given to him by the 1/2‐handful over and over…Edward sweated through his mattress…Dr.…could not save his patient.—

Clella B. Gregory, Pandemic Influenza Storybook, US Department of Health and Human Services [1]
Close Popup